Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Keith Burke Insider Profile
4 Followers
Steven Keith Burke, SVP and Chief Medical Officer at Protara Therapeutics, holds 668.84K shares in Akebia Therapeutics (Ticker: AKBA), holds 128.25K shares in Protara Therapeutics (Ticker: TARA). Most recently, Steven Keith Burke Sold ― shares of Akebia Therapeutics on May 09, 2024 for an estimated value of 31.05K.
Steven Keith Burke Protara Therapeutics (TARA)SVP and Chief Medical Officer
Protara Therapeutics (TARA)
SVP and Chief Medical Officer
Ranked #77,272 out of 99,797 Corporate Insiders
Profitable Transactions
3 out of 11 Profitable Transactions
Average Return
-11.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steven Keith Burke holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 01, 2021 - Apr 01, 2022
Return:+79.90%
The most profitable trade made by Steven Keith Burke
Steven Keith Burke's Trading History
Protara Therapeutics
Mar 18, 2019
SVP and Chief Medical Officer
Uninformative Sell
―
$664.33K
Akebia Therapeutics
May 09, 2024
SVP, Chief Medical Officer
Informative Sell
31.05K
$1.20M
List of latest transactions for each holding click on a transaction to see Steven Keith Burke's performance on stock
You May Also Like
Steven Keith Burke insider profile FAQ
What is the percentage of profitable transactions made by Steven Keith Burke?
The percentage of profitable transactions made by Steven Keith Burke is 27%.
What is the average return per transaction made by Steven Keith Burke?
The average return per transaction made by Steven Keith Burke is -11.80%.
What stocks does Steven Keith Burke hold?
Steven Keith Burke holds: TARA, AKBA stocks.
What was Steven Keith Burke’s latest transaction?
Steven Keith Burke latest transaction was an Informative Sell of $31.05K.
What was Steven Keith Burke's most profitable transaction?
Steven Keith Burke’s most profitable transaction was an Informative Sell of AKBA stock on April 1, 2021. The return on the trade was 79.90%.
What is Steven Keith Burke's role in Protara Therapeutics?
Steven Keith Burke's role in Protara Therapeutics is SVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.